ALISO VIEJO, Calif., May 31, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced thatcompany management will present an overview of the company at the Jefferies 2011 Global Healthcare Conference in New York, NY.
A live webcast and 30-day archive of this presentation will be available at http://www.avanir.com.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.
AVANIR is a trademark owned by Avanir Pharmaceuticals, Inc. All other trademarks and service marks are the property of their respective owners
Đ2011 Avanir Pharmaceuticals, Inc. All Rights Reserved.
SOURCE Avanir Pharmaceuticals, Inc.
Subscribe to our Free Newsletters!
Dysthymia or persistent depressive disorder (PDD) is a chronic low mood and self-esteem affecting ...
Vitamin A is an extremely vital vitamin needed for the eyes, skin, hair, immunity and during ...
Blood groups are of four important types determined by the presence or absence of specific ...View All